Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
Monthly Recap: China Pharmaceutical Regulatory Updates | Aug. 2021 1. NMPA Releases the 44th Batch of Reference Listed Drugs; 2. SAMR to Enforce New Rules for Medical Device and IVD Reagent Registration/Filing; 3. NMPA Announces Four Rx-to-OTC Switches...
Sep 30, 2021
Monthly Recap: China Pharmaceutical Regulatory Updates | March 2021 In Mar. 2021, the Center for Drug Evaluation released a total of seven announcements including contents such as technical requirements for drug research & evaluation. ChemLinked BaiPharm team collected the documents and summarized their keynotes.
Apr 08, 2021
- Online Conference | China Drug Regulation and Pharmaceutical Market
- China Cracks Down on Monopolies in Active Pharmaceutical Ingredient Industry
- Monthly Recap: China Pharmaceutical Regulatory Updates | Sept. 2021
- Monthly Report: New Drug Approvals in China | Sept. 2021
- China Chemical Drug Registration Classification